| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |